Goldman Sachs increased its price target on Cigna Corporation CI from $56 to $60. In a research report published today, Goldman named better than expected Q1 earnings results, which also led to an upgrade in Goldman's EPS estimate, as a reason for increasing its price target on Cigna.
In the report, Goldman states, "Following 1Q, we increase 2011/2012/2013 EPS to $5.20/$6.00/$7.00 from $4.80/$5.40/$6.05 and raise our price target to $60, implying over 27% upside."
Goldman has also reiterated its Buy rating on Cigna.
In yesterday's trading, Cigna's shares added 2.74% to their value to close the day at $47.18. Its shares continued to gain value in today's pre-market trading as well. At the moment, its share are trading at $48.28, an increase of 2.33% on yesterday's value.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Posted In: Analyst ColorEarningsPrice TargetAnalyst RatingsCIGNA CorporationGoldman SachsHealth CareManaged Health Care
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in